| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylserine 1-acylhydrolase activity | 5.39e-07 | 12 | 28 | 3 | GO:0052739 | |
| GeneOntologyMolecularFunction | phospholipase A1 activity | 2.36e-06 | 19 | 28 | 3 | GO:0008970 | |
| GeneOntologyMolecularFunction | phospholipase A2 activity | 1.86e-05 | 37 | 28 | 3 | GO:0004623 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 6.50e-05 | 157 | 28 | 4 | GO:0052689 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 3.86e-04 | 102 | 28 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | phospholipase activity | 5.35e-04 | 114 | 28 | 3 | GO:0004620 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 7.51e-04 | 807 | 28 | 6 | GO:0016788 | |
| GeneOntologyMolecularFunction | lipase activity | 9.32e-04 | 138 | 28 | 3 | GO:0016298 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.32e-03 | 51 | 28 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 4.06e-03 | 775 | 28 | 5 | GO:0016746 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 4.40e-03 | 238 | 28 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 9.13e-03 | 103 | 28 | 2 | GO:0004553 | |
| GeneOntologyBiologicalProcess | N-acylphosphatidylethanolamine metabolic process | 1.49e-07 | 9 | 26 | 3 | GO:0070292 | |
| GeneOntologyBiologicalProcess | phosphatidylethanolamine acyl-chain remodeling | 2.91e-07 | 11 | 26 | 3 | GO:0036152 | |
| GeneOntologyBiologicalProcess | phosphatidylethanolamine metabolic process | 7.06e-06 | 30 | 26 | 3 | GO:0046337 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine metabolic process | 1.27e-04 | 78 | 26 | 3 | GO:0046470 | |
| Domain | LRAT-like_dom | 1.50e-07 | 8 | 27 | 3 | IPR007053 | |
| Domain | LRAT | 1.50e-07 | 8 | 27 | 3 | PF04970 | |
| Domain | EGF_3 | 3.41e-04 | 235 | 27 | 4 | PS50026 | |
| Domain | EGF | 3.41e-04 | 235 | 27 | 4 | SM00181 | |
| Domain | EGF-like_dom | 4.25e-04 | 249 | 27 | 4 | IPR000742 | |
| Domain | EGF_1 | 4.65e-04 | 255 | 27 | 4 | PS00022 | |
| Domain | EGF-like_CS | 5.08e-04 | 261 | 27 | 4 | IPR013032 | |
| Domain | EGF_2 | 5.38e-04 | 265 | 27 | 4 | PS01186 | |
| Domain | EGF | 7.79e-04 | 126 | 27 | 3 | PF00008 | |
| Domain | LDLR_class-A_CS | 1.52e-03 | 40 | 27 | 2 | IPR023415 | |
| Domain | Ldl_recept_a | 1.92e-03 | 45 | 27 | 2 | PF00057 | |
| Domain | - | 2.00e-03 | 46 | 27 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.18e-03 | 48 | 27 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.27e-03 | 49 | 27 | 2 | IPR002172 | |
| Domain | LDLa | 2.27e-03 | 49 | 27 | 2 | SM00192 | |
| Domain | LDLRA_2 | 2.27e-03 | 49 | 27 | 2 | PS50068 | |
| Domain | Glycoside_hydrolase_SF | 2.65e-03 | 53 | 27 | 2 | IPR017853 | |
| Domain | EGF_Ca-bd_CS | 8.61e-03 | 97 | 27 | 2 | IPR018097 | |
| Domain | EGF_CA | 8.96e-03 | 99 | 27 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 9.13e-03 | 100 | 27 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.02e-02 | 106 | 27 | 2 | IPR000152 | |
| Domain | EGF_CA | 1.34e-02 | 122 | 27 | 2 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.38e-02 | 124 | 27 | 2 | IPR001881 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PE | 8.72e-06 | 29 | 20 | 3 | M702 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_DEGRADATION | 3.95e-04 | 21 | 20 | 2 | M3624 | |
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 19615464 | ||
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 22825852 | ||
| Pubmed | Structural and functional characterization of tumor suppressors TIG3 and H-REV107. | 6.25e-07 | 2 | 28 | 2 | 25871522 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 20100577 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 15264223 | ||
| Pubmed | Structural basis for the acyltransferase activity of lecithin:retinol acyltransferase-like proteins. | 1.87e-06 | 3 | 28 | 2 | 22605381 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 3.32e-04 | 168 | 28 | 3 | 30631154 | |
| Pubmed | Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. | 6.06e-04 | 45 | 28 | 2 | 23663784 | |
| Cytoband | 11q12.3 | 2.49e-04 | 38 | 28 | 2 | 11q12.3 | |
| GeneFamily | HRAS like suppressor family | 9.83e-09 | 5 | 19 | 3 | 1227 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 8.07e-05 | 990 | 24 | 7 | JC_hmvEC_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.02e-04 | 81 | 24 | 3 | GSM605865_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 1.14e-04 | 84 | 24 | 3 | GSM605862_100 | |
| ToppCell | Severe_COVID-19|World / Disease group,lineage and cell class （2021.01.30） | 6.86e-06 | 198 | 28 | 4 | 09fd456077bb3a657ad3b10c6cfe799b7266456a | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.86e-06 | 198 | 28 | 4 | 454aee3f4fe6d0beeccc55200b4495f4f9b44feb | |
| ToppCell | BAL-Severe|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.86e-06 | 198 | 28 | 4 | 687f69c16343227854c882b4a0f3930ce534a3d2 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|Fibroblasts / Location, Cell class and cell subclass | 7.14e-06 | 200 | 28 | 4 | f62833c63f9c6a94b6cc2ba8e2f960e67f093f48 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.16e-05 | 129 | 28 | 3 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.52e-05 | 142 | 28 | 3 | d60d2a5d0876a552bc161fc4e2dfe180f88f03a5 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 153 | 28 | 3 | 5fbb90b8477f9fdabf3be19efd3068fbf70abee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-04 | 153 | 28 | 3 | 2c46183481e6d5a7fa190a743062509465f88e56 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 153 | 28 | 3 | decc4f3098a9374a6b65c015a9d36380986290bf | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 153 | 28 | 3 | 36a28805c0545c2f410c74a6ca0a70d840e75715 | |
| ToppCell | 18-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 1.21e-04 | 154 | 28 | 3 | ecfaed6fbffd1305a2216d48ecb33d8a182a9dd9 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-04 | 156 | 28 | 3 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-maDC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 156 | 28 | 3 | 095281ea78aefa0ee638191a03f8d6f62a86a9ff | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 156 | 28 | 3 | 29b04143f71a0ecc600ac670abd1d521bee55fe7 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.28e-04 | 157 | 28 | 3 | 67641089eeb1a502e01fb6ea35c3d19e21a5789e | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-04 | 160 | 28 | 3 | 6d941e584360975e1fdbb2fc67af8e31f18759d8 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.41e-04 | 162 | 28 | 3 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.48e-04 | 165 | 28 | 3 | e460e03992781073cd836a655f15dda3157cea55 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Control / Condition, Lineage and Cell class | 1.54e-04 | 167 | 28 | 3 | ab6029ba037b6a499da8758864c44e174cde5587 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 167 | 28 | 3 | 484de3ca4a905067c18d06995601479eef8fc15e | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 1.54e-04 | 167 | 28 | 3 | 6e5140527437193f441ca96893b9a00d346614f3 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.56e-04 | 168 | 28 | 3 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 169 | 28 | 3 | 45ac692a0c9064ce6b6a31c2cd21c85ccf594670 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 169 | 28 | 3 | 3514a74980c7bd4bb76dbd06693f492e8dce21e0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 170 | 28 | 3 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 170 | 28 | 3 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 178 | 28 | 3 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | dd94ebe69ade6f51b94058abe066216f0de9feda | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.95e-04 | 181 | 28 | 3 | 1fa882ee66e6f835acf3f293fd24dc7f8b1eff99 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.04e-04 | 184 | 28 | 3 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 184 | 28 | 3 | 5b4f18b26d03e8e5798cac70d124534749fc4cc0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 185 | 28 | 3 | e1fd66f4295056807aa29c0e4ce6b1a79cc8dfcf | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 2.08e-04 | 185 | 28 | 3 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.11e-04 | 186 | 28 | 3 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-04 | 187 | 28 | 3 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | COVID-19_Moderate-NK_activated|COVID-19_Moderate / disease group, cell group and cell class | 2.21e-04 | 189 | 28 | 3 | 8f9f1e71857bed6d59c4b087b6a6970f30fd86be | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.21e-04 | 189 | 28 | 3 | 620d5a71b8cb6288540e2d2d848b9d4d66c1226f | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.25e-04 | 190 | 28 | 3 | 5c6801046ab88aad76697984342319872a8f9e38 | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.25e-04 | 190 | 28 | 3 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.25e-04 | 190 | 28 | 3 | 58f2278694931d4b104234810165715b510ab835 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.25e-04 | 190 | 28 | 3 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.28e-04 | 191 | 28 | 3 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 191 | 28 | 3 | beb15dcc6df156ab342fc21a60a874c868780ce4 | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 191 | 28 | 3 | 8911b88f70e5deed027177be2e6745b80308616b | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.32e-04 | 192 | 28 | 3 | 42fed1a4c88e62dffda026503e5da1eb21fe877f | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 2.32e-04 | 192 | 28 | 3 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.32e-04 | 192 | 28 | 3 | 6eadf0f37beae22838e930ad897a9b89e5e12cdb | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 2.32e-04 | 192 | 28 | 3 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 192 | 28 | 3 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-04 | 192 | 28 | 3 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | T/NK_cells-CD8+_Effector_T_cell|World / Lineage and Cell class | 2.35e-04 | 193 | 28 | 3 | 79fa0f482cd98642b1d38835cda98622f21e5bd0 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 193 | 28 | 3 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 193 | 28 | 3 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 193 | 28 | 3 | 778fcf8448e81fe18972d97ea8a30ab036d16fe5 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8_low_T|normal_Lymph_Node / Location, Cell class and cell subclass | 2.35e-04 | 193 | 28 | 3 | e20ad6b62ad3aa386aa10b7a5d057d24a64ad386 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-04 | 194 | 28 | 3 | 64535db0420e53e4d777d2333b5051e63e8a3373 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 2.39e-04 | 194 | 28 | 3 | 81b8f60d3b81e494051721ce9b8b6aefd415442c | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 2.39e-04 | 194 | 28 | 3 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-04 | 194 | 28 | 3 | b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 2.39e-04 | 194 | 28 | 3 | 40dbfdf1d7e6b73d120d8f802f08e573fe9a739e | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.39e-04 | 194 | 28 | 3 | 72749ab1dd36a0d58624328961e1db08ccba2686 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.42e-04 | 195 | 28 | 3 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 195 | 28 | 3 | eb96439b59914954f684c4bfd9e9a6dbd3201a20 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.42e-04 | 195 | 28 | 3 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 2.42e-04 | 195 | 28 | 3 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.42e-04 | 195 | 28 | 3 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.46e-04 | 196 | 28 | 3 | bcd274db4955ea76ca26267a272c7d1929db24f4 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.46e-04 | 196 | 28 | 3 | a8217c8e27027c0444ce072fe194404345c34022 | |
| ToppCell | BAL-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 2.46e-04 | 196 | 28 | 3 | c32b7b7e6a4781c19c30c6e32d5563f82355deb0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-04 | 196 | 28 | 3 | 072e0e29be4639344ead4ea6ad521e3338f5f8af | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-04 | 196 | 28 | 3 | 80b9139d91dda4de69830d2d443859e047ab5503 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 196 | 28 | 3 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM1|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.46e-04 | 196 | 28 | 3 | ea3fbe81b4ecb6ccc8031f6d99da93c9f9f8c1aa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-04 | 196 | 28 | 3 | f424c45be7f34cbef76e1696dea10c1e3a9af2e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-04 | 196 | 28 | 3 | 9bb87d20c25df0dc8e48bcb32b57f81a3dc1c0cd | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.46e-04 | 196 | 28 | 3 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 196 | 28 | 3 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 196 | 28 | 3 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.46e-04 | 196 | 28 | 3 | 7c8aa5853d7096628e35af665097c0299c329753 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-04 | 196 | 28 | 3 | f60b220ed117bcc33e0f7bbf5b53d3b1422ebaca | |
| ToppCell | COVID-19|World / Condition, Lineage and Cell class | 2.50e-04 | 197 | 28 | 3 | 228f641d79282cc3dc51b95a1f4b0cccfc200735 | |
| ToppCell | NS-critical-d_16-33-Epithelial-IRC-IFNG_responsive_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.50e-04 | 197 | 28 | 3 | 8eb007fe2a60b1bfc9d0fd5fc92d2f21388806f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.50e-04 | 197 | 28 | 3 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 2.50e-04 | 197 | 28 | 3 | a573a59e2271f5d0ce5de0b851951ab72659e060 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue | 2.50e-04 | 197 | 28 | 3 | b2f5b35e931c1342e541ecf05933350c41612415 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-04 | 197 | 28 | 3 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intermediate_macrophages|Lung / Manually curated celltypes from each tissue | 2.50e-04 | 197 | 28 | 3 | bcb4dc17dae705bd84ea6a2842d6b107562baeb7 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-04 | 197 | 28 | 3 | 0b4fdf0131dd67a86ee3209fa66db0ca2e01a10e | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-04 | 197 | 28 | 3 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | (1)_B_cell-(101)_plasma|(1)_B_cell / immune cells in Peripheral Blood (logTPM normalization) | 2.50e-04 | 197 | 28 | 3 | c86fcd779f30074bdf0b23d763fee5b7e4a6e4f5 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-04 | 197 | 28 | 3 | b3876076684781fb8384117f2cf367d828985986 | |
| ToppCell | mild_COVID-19-CD8+_Tem|World / disease group, cell group and cell class (v2) | 2.50e-04 | 197 | 28 | 3 | 97fead264e986d922669a6006cbcec530c697df7 | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-04 | 197 | 28 | 3 | 0f40dd3530eb8d02e79b32f942efe3b65b8f6ee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.50e-04 | 197 | 28 | 3 | a6aa5991d566c28440f7e24a30933e69669064f2 | |
| ToppCell | (1)_B_cell-(10)_B_cell-(101)_plasma|(10)_B_cell / immune cells in Peripheral Blood (logTPM normalization) | 2.50e-04 | 197 | 28 | 3 | c7af5510e2dd69b6a044244b22e62b82f474fdbd | |
| ToppCell | severe-Myeloid-CD14_Monocytes_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.54e-04 | 198 | 28 | 3 | cb8f099cf4ed320615b1c60ddab86b89d8db9a43 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 2.54e-04 | 198 | 28 | 3 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.54e-04 | 198 | 28 | 3 | 374d7a24e00cd3f435ca980123ab3c6a441c9ad5 | |
| ToppCell | Control-CD4+_T|Control / Disease group and Cell class | 2.54e-04 | 198 | 28 | 3 | 2682eea9b34cfc7e82891c1f1117d3c874107af6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 198 | 28 | 3 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| Disease | Major Depressive Disorder | 1.25e-03 | 243 | 26 | 3 | C1269683 | |
| Disease | physical activity measurement | 1.28e-03 | 245 | 26 | 3 | EFO_0008002 | |
| Disease | Unipolar Depression | 1.50e-03 | 259 | 26 | 3 | C0041696 | |
| Disease | ankylosing spondylitis | 2.91e-03 | 91 | 26 | 2 | EFO_0003898 | |
| Disease | urate measurement | 7.38e-03 | 895 | 26 | 4 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YAHWAIYVGDGYVVH | 21 | Q9NWW9 | |
| FHYCGSYLHAVRWIP | 446 | P54793 | |
| VAGIKFWCYHAGHVL | 146 | Q9UKF6 | |
| VAYHEAGHAVAGWYL | 571 | Q9Y4W6 | |
| RVTWYHLYDGFHGSI | 366 | Q5VUY2 | |
| YHHCFWLTVGVYVLG | 151 | Q6IF36 | |
| YYHCNRHHWVFGVLL | 81 | Q86VZ1 | |
| TQYHHGYSYILGWIC | 126 | P54849 | |
| WLCKYVYNHIGGEHS | 346 | Q9HCP6 | |
| FGLCHHGNYLFWTEY | 746 | Q07954 | |
| HKYLLVEFYAPWCGH | 41 | P07237 | |
| YICTLPLWVDYFLHH | 66 | P46093 | |
| GGEVIDSVTWHHYYL | 286 | Q9Y251 | |
| YYVWVGAKHGFTLNH | 316 | Q5VYJ5 | |
| YIIGGYYWHPLSEVH | 276 | Q8NBE8 | |
| CWHLHDYLVDTLGPY | 331 | O43820 | |
| YIVHYEGHGWDQLIT | 631 | Q6P179 | |
| IYFAGEHTAYPHGWV | 476 | Q96RQ9 | |
| YRHWAIYVGDGYVVH | 21 | P53816 | |
| CSHYGLIYPWVHVVI | 831 | Q969F9 | |
| YEHWALYIGDGYVIH | 21 | Q9UL19 | |
| LGIGGHYSLHEYSWV | 56 | Q6IA17 | |
| WEGGVCHHVYKRVYR | 1366 | Q8TER0 | |
| AVLVHAGWSCHDGYY | 321 | A6NCW7 | |
| HHVYTCGSGYIRVWD | 171 | A0A1W2PR48 | |
| VYYGGFHGSHRVIIW | 941 | Q7Z3V4 | |
| SIAGIHWYHGTEGYV | 206 | Q9P2L0 | |
| VRLWHALNGHYCGYF | 891 | B1ANS9 |